193 related articles for article (PubMed ID: 27341022)
21. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
[TBL] [Abstract][Full Text] [Related]
22. Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain.
Liao WL; Heo GY; Dodder NG; Reem RE; Mast N; Huang S; Dipatre PL; Turko IV; Pikuleva IA
J Proteome Res; 2011 Jan; 10(1):241-8. PubMed ID: 21049985
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis.
Lugli A; Zlobec I; Minoo P; Baker K; Tornillo L; Terracciano L; Jass JR
Histopathology; 2007 Mar; 50(4):453-64. PubMed ID: 17448021
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemistry detects mismatch repair gene defects in colorectal cancer.
Hameed F; Goldberg PA; Hall P; Algar U; van Wijk R; Ramesar R
Colorectal Dis; 2006 Jun; 8(5):411-7. PubMed ID: 16684085
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional regulation and functional characterization of the oxysterol/EBI2 system in primary human macrophages.
Preuss I; Ludwig MG; Baumgarten B; Bassilana F; Gessier F; Seuwen K; Sailer AW
Biochem Biophys Res Commun; 2014 Apr; 446(3):663-8. PubMed ID: 24480442
[TBL] [Abstract][Full Text] [Related]
26. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.
Dihlmann S; Tao S; Echterdiek F; Herpel E; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Kloor M
Int J Cancer; 2014 Nov; 135(10):2387-96. PubMed ID: 24729378
[TBL] [Abstract][Full Text] [Related]
27. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
[TBL] [Abstract][Full Text] [Related]
28. Distinctive patterns of p53 protein expression and microsatellite instability in human colorectal cancer.
Nyiraneza C; Jouret-Mourin A; Kartheuser A; Camby P; Plomteux O; Detry R; Dahan K; Sempoux C
Hum Pathol; 2011 Dec; 42(12):1897-910. PubMed ID: 21665242
[TBL] [Abstract][Full Text] [Related]
29. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
[TBL] [Abstract][Full Text] [Related]
30. Cyclooxygenase 2 expression in colorectal cancer with DNA mismatch repair deficiency.
Castells A; Payá A; Alenda C; Rodríguez-Moranta F; Agrelo R; Andreu M; Piñol V; Castellví-Bel S; Jover R; Llor X; Pons E; Elizalde JI; Bessa X; Alcedo J; Saló J; Medina E; Naranjo A; Esteller M; Piqué JM;
Clin Cancer Res; 2006 Mar; 12(6):1686-92. PubMed ID: 16551850
[TBL] [Abstract][Full Text] [Related]
31. TIA-1 cytotoxic granule-associated RNA binding protein improves the prognostic performance of CD8 in mismatch repair-proficient colorectal cancer.
Zlobec I; Karamitopoulou E; Terracciano L; Piscuoglio S; Iezzi G; Muraro MG; Spagnoli G; Baker K; Tzankov A; Lugli A
PLoS One; 2010 Dec; 5(12):e14282. PubMed ID: 21179245
[TBL] [Abstract][Full Text] [Related]
32. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
[TBL] [Abstract][Full Text] [Related]
33. Cell-free DNA blood levels in colorectal cancer patients do not correlate with mismatch repair-proficiency.
Lazarev I; Leibovitch L; Czeiger D; Sion-Vardi N; Geffen DB; Douvdevani A; Ariad S
In Vivo; 2014; 28(3):349-54. PubMed ID: 24815837
[TBL] [Abstract][Full Text] [Related]
34. Mismatch repair, minichromosome maintenance complex component 2, cyclin A, and transforming growth factor β receptor type II as prognostic factors for colorectal cancer: results of a 10-year prospective study using tissue microarray analysis.
Zhao DB; Chandler I; Chen ZM; Pan HC; Popat S; Shao YF; Houlston RS
Chin Med J (Engl); 2011 Feb; 124(4):483-90. PubMed ID: 21362268
[TBL] [Abstract][Full Text] [Related]
35. Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival.
Li P; Xiao Z; Braciak TA; Ou Q; Chen G; Oduncu FS
PLoS One; 2017; 12(8):e0181615. PubMed ID: 28767665
[TBL] [Abstract][Full Text] [Related]
36. PD-L1 protein expression in tumour cells and immune cells in mismatch repair protein-deficient and -proficient colorectal cancer: the foundation study using the SP142 antibody and whole section immunohistochemistry.
El Jabbour T; Ross JS; Sheehan CE; Affolter KE; Geiersbach KB; Boguniewicz A; Ainechi S; Bronner MP; Jones DM; Lee H
J Clin Pathol; 2018 Jan; 71(1):46-51. PubMed ID: 28667193
[TBL] [Abstract][Full Text] [Related]
37. Lymph node yield after colectomy for cancer: is absence of mismatch repair a factor?
Samdani T; Schultheis M; Stadler Z; Shia J; Fancher T; Misholy J; Weiser MR; Nash GM
Dis Colon Rectum; 2015 Mar; 58(3):288-93. PubMed ID: 25664706
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL
Oncologist; 2016 May; 21(5):618-25. PubMed ID: 27009937
[TBL] [Abstract][Full Text] [Related]
39. Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance.
Scarpa M; Ruffolo C; Canal F; Scarpa M; Basato S; Erroi F; Fiorot A; Dall'Agnese L; Pozza A; Porzionato A; Castagliuolo I; Dei Tos AP; Bassi N; Castoro C
Oncotarget; 2015 Dec; 6(41):43472-82. PubMed ID: 26496037
[TBL] [Abstract][Full Text] [Related]
40. 2-Hydroxypropyl-β-cyclodextrin reduces retinal cholesterol in wild-type and Cyp27a1
El-Darzi N; Mast N; Petrov AM; Pikuleva IA
Br J Pharmacol; 2021 Aug; 178(16):3220-3234. PubMed ID: 32698250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
